Article
Heterogeneity in the presentation of clinical type 1 diabetes defined by the level of risk conferred by human leukocyte antigen class II genotypes.
Pediatric diabetes - 1 Mar 2022
Taka Antti-Mathias, Härkönen Taina, Vähäsalo Paula, Lempainen Johanna, Veijola Riitta, Ilonen Jorma, Knip Mikael
Abstract excerpt
OBJECTIVES: The association between human leukocyte antigen (HLA) class II genotypes and susceptibility to type 1 diabetes (T1D) is well established. This study aimed at examining whether there are differences in the presentation of T1D depending on the HLA genotype. RESEARCH DESIGN AND METHODS: We divided the study participants (N = 5798) in the Finnish Pediatric Diabetes Register into two groups based on the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
